An electrochemical sensor based on label-free functional allosteric molecular beacons for detection target DNA/miRNA

Biosensors & Bioelectronics
Zhimin CaiXi Chen


We report two novel electrochemical sensors (E-sensors) for the detection of target DNA and miRNA. The E-sensors were fabricated using label-free functional allosteric molecular beacons (aMBs), which can form streptavidin aptamers to bind to streptavidin peroxidase polymer and so generate catalytic currents in the presence of the targets. These E-sensors eliminate the antigen antibody interactions which require sophisticated DNA modification. During the experiment, we found a pair of CV peaks located at around 0.17 V. These peaks contributed to the redox reaction between TMB and TMB(+), and the adsorption-desorption process of TMB(+) to the negative aMB backbone. When the E-sensor was hybridized with the complement of the aMB sequence, a pair of CV peaks were found at around 0.47 V which were related to the redox reaction between TMB(+) and TMB(2+), and the process of intercalation of the planar structure of TMB(2+) to dsDNA. The RSV-aMB E-sensor could detect 44 amol RSV DNA in the 4 μL sample and performed well in complicated biological environments. The let-7a-aMB E-sensor reached a detection limit of 13.6 amol let-7a miRNA in the 4 μL sample and showed good selectivity for one base mismatched miRNA.


Oct 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H G Rennke, M A Venkatachalam
Feb 13, 2003·Journal of the American Chemical Society·John F SmalleyMarshall D Newton
Jul 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chunhai FanAlan J Heeger
Dec 22, 2005·Journal of the American Chemical Society·Yi XiaoAlan J Heeger
Sep 27, 2006·Journal of Biotechnology·Filiz M AslanCharles R Cantor
Oct 27, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yi XiaoAlan J Heeger
Nov 13, 2007·Angewandte Chemie·Alastair W WarkRobert M Corn
May 8, 2008·Journal of the American Chemical Society·Gang LiuChunhai Fan
Mar 6, 2010·Accounts of Chemical Research·Arica A Lubin, Kevin W Plaxco
Mar 13, 2010·Accounts of Chemical Research·Di LiChunhai Fan
Feb 15, 2011·Analytical Chemistry·Elaheh FarjamiElena E Ferapontova
Aug 9, 2011·Accounts of Chemical Research·Michael Famulok, Günter Mayer
Mar 8, 2012·Journal of the American Chemical Society·Bin-Cheng YinBang-Ce Ye


Dec 15, 2015·Analytical Chemistry·Richard M Graybill, Ryan C Bailey
Jan 7, 2015·Biosensors & Bioelectronics·Mahmoud Labib, Maxim V Berezovski
Dec 24, 2014·Bioanalysis·Ilaria Palchetti
Feb 18, 2014·Chemical Communications : Chem Comm·Jinbo ZhuErkang Wang
Jun 4, 2014·Biosensors & Bioelectronics·Li JiangJiong Li
Oct 31, 2018·The Analyst·Philip GillespieDanny O'Hare
Feb 23, 2017·Veterinary Research·Jasmina VidicNicole Jaffrezic-Renault
Feb 7, 2014·The Analyst·Blake N Johnson, Raj Mutharasan

Related Concepts

DNA, Double-Stranded
Medical Device Design
Poly(A) Tail
Staining and Labeling
Molecular Probe Techniques
Biosensing Techniques
Prosthesis Failure Analysis
Aptamers, Nucleotide
Amphotericin B

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.